Detalhe da pesquisa
1.
Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice.
Respir Res
; 25(1): 7, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178222
2.
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice.
BMC Immunol
; 23(1): 21, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468726
3.
Orally administered recombinant baculovirus vaccine elicits partial protection against avian influenza virus infection in mice.
Microb Pathog
; 149: 104495, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910984
4.
Vaccine efficacy induced by virus-like particles containing Leishmania donovani surface glycoprotein GP63.
PLoS Negl Trop Dis
; 18(6): e0012229, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38857253
5.
Crossprotection induced by virus-like particles containing influenza dual-hemagglutinin and M2 ectodomain.
Nanomedicine (Lond)
; 19(9): 741-754, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390688
6.
Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1.
Parasites Hosts Dis
; 62(2): 193-204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835260
7.
Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection.
Pharmaceutics
; 15(3)2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986643
8.
The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques.
Parasites Hosts Dis
; 61(4): 418-427, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043537
9.
Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing Leishmania donovani Surface Antigen.
ACS Infect Dis
; 9(12): 2583-2592, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014824
10.
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein.
PLoS One
; 18(4): e0283928, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104285
11.
Chitosan-Alginate Polymeric Nanocomposites as a Potential Oral Vaccine Carrier Against Influenza Virus Infection.
ACS Appl Mater Interfaces
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903218
12.
Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice.
Life (Basel)
; 12(7)2022 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35888065
13.
Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus.
Biomedicines
; 10(7)2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884922
14.
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection.
Vaccines (Basel)
; 10(2)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214611
15.
Recombinant Vaccinia Virus Expressing Plasmodium berghei Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against P. berghei Infection in Mice.
Trop Med Infect Dis
; 7(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355892
16.
Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
Viruses
; 14(2)2022 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216022
17.
Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection.
Biomedicines
; 10(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36359332
18.
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18.
Vaccines (Basel)
; 10(10)2022 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36298453
19.
Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei.
Biomedicines
; 10(9)2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140395
20.
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains.
Vaccines (Basel)
; 9(8)2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452044